Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALKERMES PLC

(ALKS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ALKERMES PLC
07/29ALKERMES : Reports Second Quarter 2021 Financial Results
AQ
07/29ALKERMES : Mizuho Securities Adjusts Alkermes' Price Target to $33 From $29, Mai..
MT
07/29ALKERMES : SVB Leerink Adjusts Alkermes' Price Target to $25 From $23, Keeps Mar..
MT
07/28ALKERMES : Reports Earnings, Revenue Increase for Q2, Raises Full-Year Guidance
MT
07/28ALKERMES : Q2 2021 Earnings slides Final 7 27 21 607pm.pdf
PU
07/28ALKERMES : Q2 Earnings Snapshot
AQ
07/28ALKERMES : Reports Second Quarter 2021 Financial Results (Form 8-K)
PU
07/28GUIDANCE : (ALKS) ALKERMES Forecasts Fiscal Year 2021 EPS Range $0.52 - $0.70
MT
07/28Alkermes plc Revises Earnings Guidance for the Full Year 2021
CI
07/28ALKERMES : Earnings Flash (ALKS) ALKERMES Posts Q2 Revenue $10M, vs. Street Est ..
MT
07/28ALKERMES : Earnings Flash (ALKS) ALKERMES Reports Q2 EPS $0.30, vs. Street Est o..
MT
07/28Alkermes plc Reports Earnings Results for the Second Quarter Ended June 30, 2..
CI
07/26ALKERMES : Announces Recipients of 2021 Alkermes Inspiration Grants Program
AQ
07/21ALKERMES : to Report Second Quarter 2021 Financial Results on July 28, 2021
PR
06/30ALKERMES : Presented New Data Analysis on Healthcare Resource Use Among Veterans..
PR
06/30Alkermes Presents New Data Analysis on Healthcare Resource Use Among Veterans..
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) dropped from Russell Midcap Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) dropped from Russell 1000 Value Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 2000 Growth-Defensive Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 3000E Growth Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) dropped from Russell 1000 Dynamic Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) dropped from Russell 1000 Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 2000 Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 2000 Defensive Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) dropped from Russell 2500 Value Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 2000 Dynamic Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) dropped from Russell 3000E Value Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 2500 Growth Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) dropped from Russell Midcap Value Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) dropped from Russell 3000 Value Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 3000 Growth Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell Small Cap Comp Growth Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) dropped from Russell Small Cap Comp Value Index
CI
06/25ALKERMES PLC(NASDAQGS : ALKS) added to Russell 2000 Growth Index
CI
06/23ALKERMES : Announces Former Professional Baseball Player CC Sabathia, as Spokesp..
AQ
06/22ALKERMES : Announces Former Professional Baseball Player, CC Sabathia, as Spokes..
PR
06/14ALKERMES : Stock Option and Incentive Plan, as amended (Form 8-K)
PU
06/07ALKERMES : Presents New Data on Nemvaleukin Alfa at 2021 American Society of Cli..
AQ
06/05ALKERMES : ALKS FINAL_ASCO21 Nemva IR Call 6.4.21 9.00am.pdf
PU
06/04ALKERMES : Presents Nemvaleukin Alfa Data at American Society of Clinical Oncolo..
MT
06/04Alkermes plc Presents New Data on Nemvaleukin Alfa At 2021 American Society o..
CI
06/03ALKERMES : to Take Part in the Goldman Sachs Annual Global Healthcare Conference
PR
06/02ALKERMES : Announces FDA Approval of LYBALVI for the Treatment of Schizophrenia ..
AQ
06/02ALKERMES : HC Wainwright Adjusts Alkermes' Price Target to $25 From $24, Keeps N..
MT
06/01SECTOR UPDATE : Health Care Stocks Trying to Make Gains Ahead of Tuesday Opener
MT
06/01SECTOR UPDATE : Health Care
MT
06/01ALKERMES : Receives FDA Approval for Lybalvi to Treat Schizophrenia, Bipolar Dis..
MT
06/01ALKERMES : schizophrenia drug gets U.S. FDA approval
RE
06/01ALKERMES : Announces FDA Approval of LYBALVI™ for the Treatment of Schizop..
PU
06/01ALKERMES : schizophrenia drug gets U.S. FDA nod
RE
06/01Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophreni..
CI
05/31ALKERMES : to Host Webcast With Expert Oncologist Panel to Discuss Data on Nemva..
AQ
05/20ALKERMES : Announces the Appointment of Emily Peterson Alva to its Board of Dire..
PU
05/20Alkermes plc Appoints Emily Peterson Alva as New Independent Director
CI
05/20ALKERMES : Announces the Appointment of Emily Peterson Alva to its Board of Dire..
PR
05/14ALKERMES : Announces 2021 Alkermes Inspiration Grants Program to Support Innovat..
AQ
05/13ALKERMES : Announces 2021 Alkermes Inspiration Grants® Program to Support Innova..
PR
05/10Sarissa Capital Enters into Agreement with Alkermes
CI
05/05ALKERMES : to Take Part in the BofA Securities 2021 Virtual Healthcare Conferenc..
PR
05/04ALKERMES : to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Con..
AQ
04/30ALKERMES : Grants Sarissa Capital Right to Appoint Director to Board
MT
04/30ALKERMES : Announces Agreement with Sarissa Capital
PR
04/29ALKERMES : HC Wainwright Adjusts Alkermes' Price Target to $24 From $23, Maintai..
MT
04/28Tranche Update on Alkermes plc's Equity Buyback Plan announced on November 21..
CI
04/28ALKERMES : Q1 Adjusted Earnings, Revenue Rise; Reiterates Full-Year 2021 Outlook
MT
04/28ALKERMES : Q1 Earnings Snapshot
AQ
04/28Alkermes plc Provides Earnings Guidance for the Year Ending December 31, 2021
CI
04/28Alkermes plc Announces Two Abstracts Accepted for Presentation at 2021 Americ..
CI
04/28Alkermes plc Reports Earnings Results for the First Quarter Ended March 31, 2..
CI
04/28ALKERMES : Earnings Flash (ALKS) ALKERMES Posts Q1 EPS $0.11
MT
04/28ALKERMES PLC : Reports First Quarter 2021 Financial Results
PR
04/27ALKERMES : Launches New Disease State Website to Offer Education About Alcohol D..
PR
04/27ALKERMES : Fiscal Year 2020 Irish Financial Statements
PU
04/27ALKERMES : Initiates Phase 2 Trial of Nemvaleukin Alfa Monotherapy in Patients W..
MT
04/27ALKERMES : Initiates ARTISTRY-6 Trial of Nemvaleukin Alfa Monotherapy in Patient..
PR
1  2  3  4  5  6  7  8Next
Upcoming event on ALKERMES PLC